Reorganization and functional divergence of the CD4+ memory T cell compartment in hidradenitis suppurativa

• by Laura Casals-Diaz, Jorge Romaní, Abir Ezzaanouni, Madalina Raducu, Cristina Vila, Lluís Boix, Amadeu Gavaldà, Antonio Guilabert

• July 14, 2026

Cancer Risk Assessment in Individuals with Hidradenitis Suppurativa: A Comprehensive Review and Meta-Analysis

• by Daniel Isufi, Mikkel Bak Jensen, Nikolai Loft, Rune Kjærsgaard Andersen

• March 11, 2026

FDA Approves Secukinumab for Adolescents With Moderate to Severe Hidradenitis Suppurativa

Secukinumab becomes the only interleukin-17A inhibitor approved for pediatric patients aged 12 years and older with moderate to severe hidradenitis suppurativa.

• by Kathryn Wighton

• March 13, 2026

• 2 min

When Obesity Meets Infection Risk

Researchers analyze data from Finnish cohorts and the UK Biobank to examine how body mass index relates to severe infections and their global burden.

• by Kathryn Wighton

• February 10, 2026

• 4 min